Growth Metrics

Celularity (CELU) Non-Current Deffered Revenue (2020 - 2025)

Celularity has reported Non-Current Deffered Revenue over the past 6 years, most recently at $2.8 million for Q3 2025.

  • Quarterly results put Non-Current Deffered Revenue at $2.8 million for Q3 2025, up 4.74% from a year ago — trailing twelve months through Sep 2025 was $2.8 million (up 4.74% YoY), and the annual figure for FY2024 was $2.7 million, down 14.5%.
  • Non-Current Deffered Revenue for Q3 2025 was $2.8 million at Celularity, down from $2.9 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for CELU hit a ceiling of $10.8 million in Q1 2021 and a floor of $1.8 million in Q3 2021.
  • Median Non-Current Deffered Revenue over the past 5 years was $2.7 million (2024), compared with a mean of $3.4 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: plummeted 83.51% in 2021 and later surged 46.18% in 2023.
  • Celularity's Non-Current Deffered Revenue stood at $1.9 million in 2021, then increased by 18.6% to $2.2 million in 2022, then skyrocketed by 43.58% to $3.2 million in 2023, then dropped by 14.5% to $2.7 million in 2024, then increased by 1.47% to $2.8 million in 2025.
  • The last three reported values for Non-Current Deffered Revenue were $2.8 million (Q3 2025), $2.9 million (Q2 2025), and $2.8 million (Q1 2025) per Business Quant data.